T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 101 filers reported holding T2 BIOSYSTEMS INC in Q2 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,470,000 | -65.7% | 820,499 | -15.2% | 0.63% | -13.4% |
Q3 2018 | $7,209,000 | -7.4% | 967,585 | -3.8% | 0.72% | -53.9% |
Q2 2018 | $7,788,000 | -40.5% | 1,006,175 | -50.1% | 1.57% | -6.5% |
Q1 2018 | $13,094,000 | +36.9% | 2,017,572 | -13.1% | 1.68% | +12.3% |
Q4 2017 | $9,566,000 | +14.2% | 2,321,800 | +16.4% | 1.49% | -1.5% |
Q3 2017 | $8,378,000 | +50.3% | 1,994,685 | +14.8% | 1.52% | +38.3% |
Q2 2017 | $5,576,000 | -22.3% | 1,737,085 | +27.3% | 1.10% | -19.0% |
Q1 2017 | $7,175,000 | 0.0% | 1,364,085 | 0.0% | 1.35% | +4.0% |
Q4 2016 | $7,175,000 | -24.2% | 1,364,085 | +4.3% | 1.30% | -41.8% |
Q3 2016 | $9,467,000 | -3.6% | 1,307,639 | +5.0% | 2.24% | -29.4% |
Q2 2016 | $9,824,000 | +80.4% | 1,245,138 | +125.5% | 3.17% | +132.0% |
Q1 2016 | $5,445,000 | +17.7% | 552,255 | +30.6% | 1.37% | +128.8% |
Q4 2015 | $4,627,000 | +227.9% | 422,931 | +365.2% | 0.60% | +153.0% |
Q1 2015 | $1,411,000 | -19.3% | 90,909 | 0.0% | 0.24% | -31.2% |
Q4 2014 | $1,749,000 | +6.3% | 90,909 | 0.0% | 0.34% | -21.3% |
Q3 2014 | $1,645,000 | – | 90,909 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 760,610 | $393,000 | 0.06% |
Virtu Financial LLC | 272,090 | $140,000 | 0.01% |
Founders Capital Management | 40,000 | $21,000 | 0.01% |
Continuum Advisory, LLC | 50,000 | $26,000 | 0.01% |
LEVIN CAPITAL STRATEGIES, L.P. | 113,451 | $59,000 | 0.01% |
McAdam, LLC | 113,201 | $58,000 | 0.01% |
Patriot Financial Group Insurance Agency, LLC | 50,600 | $26,000 | 0.00% |
Navis Wealth Advisors, LLC | 10,000 | $5,000 | 0.00% |
BRAVE ASSET MANAGEMENT INC | 26,400 | $14,000 | 0.00% |
COURIER CAPITAL LLC | 81,500 | $42,000 | 0.00% |